Cora Capital Advisors LLC Sells 113 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Cora Capital Advisors LLC lowered its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,796 shares of the financial services provider’s stock after selling 113 shares during the period. Cora Capital Advisors LLC’s holdings in iShares Biotechnology ETF were worth $237,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in IBB. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $29,000. Highline Wealth Partners LLC bought a new position in iShares Biotechnology ETF in the third quarter worth approximately $30,000. Ashton Thomas Securities LLC acquired a new stake in iShares Biotechnology ETF in the third quarter valued at approximately $36,000. Modus Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $41,000. Finally, Voisard Asset Management Group Inc. acquired a new position in shares of iShares Biotechnology ETF during the third quarter worth approximately $59,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $137.30 on Friday. The company has a fifty day simple moving average of $136.04 and a 200 day simple moving average of $141.80. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.